Seven Eight Capital’s Tandem Diabetes Care TNDM Stock Holding History

Seven Eight Capital’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-51,861	Closed	-$1.27M	–	743
2023 Q2	$1.27M	Buy	+51,861	New	+$1.67M	0.21%	158
2021 Q4	–	Sell	-13,514	Closed	-$1.61M	–	672
2021 Q3	$1.61M	Buy	+13,514	New	+$1.49M	0.16%	218
2021 Q2	–	Sell	-3,114	Closed	-$298K	–	706
2021 Q1	$298K	Hold	3,114	–	–	0.07%	326
2020 Q4	$298K	Sell	3,114 -7,986	-72%	-$823K	0.07%	330
2020 Q3	$1.26M	Buy	+11,100	New	+$1.17M	0.27%	110
2019 Q2	–	Sell	-68,539	Closed	-$4.35M	–	734
2019 Q1	$4.35M	Buy	+68,539	New	+$3.6M	0.23%	135

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Seven Eight Capital's TNDM Position: Q3 2023 in Review

Seven Eight Capital sold out of Tandem Diabetes Care (TNDM) in Q3 2023, closing a stake of 51,861 shares — an estimated $1.27M sold.

Seven Eight Capital first reported a position in TNDM in Q1 2019 and held it in 6 quarters. The position peaked at $4.35M in Q1 2019. 226 funds tracked by Wall St. Rank hold TNDM as of Q3 2023.

Seven Eight Capital reported no remaining Tandem Diabetes Care position as of Q3 2023 after selling out during the quarter.
Seven Eight Capital sold 51,861 Tandem Diabetes Care shares in Q3 2023, an estimated $1.27M.
Seven Eight Capital first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 6 quarters.
Seven Eight Capital's Tandem Diabetes Care position peaked at $4.35M in Q1 2019.
226 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2023.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.